BeStock  

Baxter International Inc BAX

US equityMarket cap rank #1210Medical Instruments & Supplies
$25.39 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.43 +0.16%
Open$25.45
Prev close$25.39
Day range$24.85 – $26.09
Volume4.32M
Market cap$13.14B
P/E (TTM)–
Dividend yield0.16%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$2.98B+5.0% YoY
Operating profit$225.00M+30.8% YoY
Net profit$294.00M+739.1% YoY
Diluted EPS$0.57+733.3% YoY
Free cash flow$448.00M+255.6% YoY
Operating cash flow$558.00M

Revenue, last 8 quarters

$2.8BDec '24$2.6BMar '25$2.8BJun '25$2.8BSep '25$3.0BDec '25$2.7BMar '26$3.0BJun '26$3.0BSep '26

Net profit, last 8 quarters

$-510.0MDec '24$126.0MMar '25$91.0MJun '25$-46.0MSep '25$-1.1BDec '25$-15.0MMar '26$126.0MJun '26$294.0MSep '26

Diluted EPS by quarter

-1.00Dec '240.25Mar '250.18Jun '25-0.09Sep '25-2.19Dec '25-0.03Mar '260.24Jun '260.57Sep '26

Free cash flow by quarter

$351.0MDec '24$-315.0MMar '25$68.0MJun '25$126.0MSep '25$444.0MDec '25$76.0MMar '26$166.0MJun '26$448.0MSep '26

Annual revenue

$11.7BFY20$12.1BFY21$10.1BFY22$10.4BFY23$10.6BFY24$11.2BFY25

Profitability & balance sheet

Gross margin30.1%
Operating margin2.3%
Net margin-6.2%
Return on equity-10.5%
Return on assets-3.6%
Return on invested capital-3.6%
Current ratio1.79
Liabilities / assets66.6%
Cash & investments$1.98B
Total debt$8.81B
Net cash (debt)-$6.83B
Free cash flow / sales9.8%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Medical Products and Therapies$2.10B 70.6%
  • Healthcare Systems and Technologies$806.00M 27.1%
  • Other$68.00M 2.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $2.98B $2.96B $2.70B $11.24B $2.97B
Total Operating Revenue $2.98B $2.96B $2.70B $11.24B $2.97B
Cost of Revenue $1.98B $1.93B $1.81B $7.87B $2.40B
Gross Profit $994.00M $1.03B $891.00M $3.38B $577.00M
Operating Expense $769.00M $815.00M $825.00M $3.20B $821.00M
Selling and Admin Expenses $730.00M $735.00M $728.00M $2.89B $761.00M
Research & Development $125.00M $129.00M $139.00M $518.00M $126.00M
Other Operating Expenses -$86.00M -$49.00M -$42.00M -$206.00M -$66.00M
Operating Profit $225.00M $217.00M $66.00M $177.00M -$244.00M
Net Non-Operating Interest Income (Expense) -$61.00M -$64.00M -$66.00M -$238.00M -$58.00M
Non-Operating Interest Income $13.00M $13.00M $12.00M $52.00M $11.00M
Non-Operating Interest Expense $74.00M $77.00M $78.00M $290.00M $69.00M
Other Income (Expense) $253.00M $5.00M -$6.00M -$444.00M -$454.00M
Gain on Sale of Security -$6.00M -$2.00M -$7.00M -$17.00M $0.00
Special Income (Charges) $253.00M $0.00 -$5.00M -$478.00M -$469.00M
-Less:Other Special Charges -$253.00M – – -$16.00M –
-Less:Write Off $0.00 $0.00 $5.00M $9.00M $0.00
Other Non-Operating Income (Expenses) $6.00M $7.00M $6.00M $51.00M $15.00M
Pretax Profit $417.00M $158.00M -$6.00M -$505.00M -$756.00M
Tax $119.00M $23.00M $11.00M $395.00M $279.00M
Net Profit $294.00M $126.00M -$15.00M -$957.00M -$1.13B
Profit from Continuing Operations $298.00M $135.00M -$17.00M -$900.00M -$1.04B
Net Income from Discontinuous Operations -$4.00M -$9.00M $2.00M -$57.00M -$93.00M
Minority Interests $0.00 $0.00 $0.00 $0.00 $0.00
Net Income to Parent Company $294.00M $126.00M -$15.00M -$957.00M -$1.13B
Net Income to Common Stockholders $294.00M $126.00M -$15.00M -$957.00M -$1.13B
Basic EPS $0.57 $0.24 -$0.03 -$1.87 -$2.19
Diluted EPS $0.57 $0.24 -$0.03 -$1.87 -$2.19
Dividend Per Share $0.01 $0.01 $0.01 $0.52 $0.01
-Less:Impairment of Capital Assets – – – $485.00M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $19.41B $19.79B $19.85B $20.06B $20.06B
Total Current Assets $6.83B $6.99B $6.85B $6.87B $6.87B
Cash and Cash Equivalents & Short-Term Investments $1.98B $2.15B $2.02B $1.97B $1.97B
-Cash and Cash Equivalents $1.98B $2.15B $2.02B $1.97B $1.97B
Receivables $1.78B $1.86B $1.70B $1.93B $1.93B
-Accounts Receivable $1.78B $1.86B $1.70B $1.86B $1.86B
Inventory $2.30B $2.26B $2.32B $2.23B $2.23B
Other Current Assets $768.00M $724.00M $816.00M $481.00M $481.00M
Total Non-Current Assets $12.59B $12.80B $13.00B $13.18B $13.18B
Net PPE $3.13B $3.17B $3.19B $3.19B $3.19B
-Gross PPE $8.46B $8.44B $8.38B $8.33B $8.33B
-Accumulated Depreciation -$5.33B -$5.26B -$5.19B -$5.14B -$5.14B
Goodwill and Other Intangible Assets $8.80B $8.96B $9.12B $9.30B $9.30B
-Goodwill $4.87B $4.89B $4.90B $4.93B $4.93B
-Other Intangible Assets $3.93B $4.07B $4.22B $4.37B $4.37B
Other Non-Current Assets $657.00M $669.00M $692.00M $204.00M $204.00M
Total Liabilities $12.94B $13.61B $13.83B $13.95B $13.95B
Total Current Liabilities $3.81B $3.59B $3.69B $2.97B $2.97B
Payables $1.02B $1.03B $1.09B $1.18B $1.18B
-Accounts Payable $1.02B $1.03B $1.09B $999.00M $999.00M
Current Accrued Expenses $1.94B $1.71B $1.77B $999.00M $999.00M
Short-Term Debt and Capital Lease Obligation $844.00M $844.00M $842.00M $84.00M $84.00M
-Current Debt $844.00M $844.00M $842.00M $3.00M $3.00M
Total Non-Current Liabilities $9.13B $10.02B $10.14B $10.98B $10.98B
Long Term Debt and Capital Lease Obligation $7.96B $8.82B $8.85B $9.70B $9.70B
-Long Term Debt $7.76B $8.62B $8.62B $9.47B $9.47B
-Long Term Capital Lease Obligation $206.00M $208.00M $224.00M $223.00M $223.00M
Other Non-Current Liabilities $1.17B $1.20B $1.29B $192.00M $192.00M
Total Equity $6.48B $6.18B $6.02B $6.10B $6.10B
Stockholders' Equity $6.50B $6.21B $6.04B $6.13B $6.13B
Capital Stock $683.00M $683.00M $683.00M $683.00M $683.00M
-Common Stock $683.00M $683.00M $683.00M $683.00M $683.00M
Additional Paid-In Capital $6.25B $6.24B $6.21B $6.37B $6.37B
Retained Earnings $14.10B $13.81B $13.69B $13.71B $13.71B
Less: Treasury Stock -$10.69B -$10.71B -$10.74B -$10.87B -$10.87B
Gains/Losses Not Affecting Retained Earnings -$3.85B -$3.82B -$3.80B -$3.75B -$3.75B
Minority Interests -$27.00M -$27.00M -$27.00M -$27.00M -$27.00M
-Other Receivables – – – $71.00M $71.00M
Prepaid Assets – – – $261.00M $261.00M
Investments and Advances – – – $103.00M $103.00M
Non Current Accounts Receivables – – – $126.00M $126.00M
Defined Pension Benefit – – – $66.00M $66.00M
Non-Current Deferred Assets – – – $200.00M $200.00M
-Total Tax Payable – – – $179.00M $179.00M
-Dividends Payable – – – $5.00M $5.00M
-Current Capital Lease Obligation – – – $81.00M $81.00M
Current Deferred Liabilities – – – $141.00M $141.00M
Other Current Liabilities – – – $127.00M $127.00M
Long Term Accounts Payable and Other Payables – – – $146.00M $146.00M
Non-Current Liabilities – – – $31.00M $31.00M
Non-Current Deferred Liabilities – – – $281.00M $281.00M
Employee Benefits – – – $637.00M $637.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $558.00M $285.00M $213.00M $845.00M $584.00M
Net cash flow from continuing operations $558.00M $297.00M $213.00M $951.00M $596.00M
Net Income from Continuing Operations $298.00M $135.00M -$17.00M -$900.00M -$1.04B
Gain/Loss from Continuing Operations -$257.00M -$4.00M -$4.00M -$48.00M -$24.00M
Depreciation & Depletion & Amortization $239.00M $239.00M $237.00M $981.00M $240.00M
Deferred Tax -$34.00M -$34.00M $29.00M $77.00M $192.00M
Other Non-Cash Items -$9.00M $9.00M $13.00M $30.00M $8.00M
Change in Working Capital $238.00M -$81.00M -$55.00M -$108.00M $400.00M
-Change in Receivables $74.00M -$156.00M $152.00M -$132.00M -$88.00M
-Change in Inventory -$46.00M $59.00M -$95.00M -$119.00M $241.00M
-Change in Prepaid Assets -$44.00M $79.00M $2.00M $72.00M $104.00M
-Change in Payables and Accrued Expense $243.00M -$81.00M -$101.00M $152.00M $157.00M
-Change In Other Working Capital $11.00M $18.00M -$13.00M -$81.00M -$14.00M
Cash Flow from Discontinued Operating Activities $0.00 -$12.00M $0.00 -$106.00M -$12.00M
Net cash flow from investing -$110.00M -$117.00M -$133.00M $2.84B -$198.00M
Net Cash Flow from Continuing Investing Activities -$110.00M -$117.00M -$133.00M -$464.00M -$114.00M
Capital Expenditure -$110.00M -$116.00M -$137.00M -$513.00M -$140.00M
Net Intangibles Purchase and Sale $0.00 – – -$9.00M $0.00
Net Other Investing Changes $0.00 $2.00M $4.00M $58.00M $26.00M
Financing Cash Flow -$620.00M -$31.00M -$11.00M -$4.22B -$147.00M
Net Cash Flow from Continuing Financing Activities -$620.00M -$31.00M -$11.00M -$4.22B -$147.00M
Net Issuance Payments Of Debt -$600.00M $0.00 $0.00 -$3.79B $14.00M
Cash Dividends Paid -$5.00M -$5.00M -$5.00M -$348.00M -$87.00M
Proceeds from Stock Option Exercised $6.00M $5.00M $8.00M $30.00M $5.00M
Net Other Financing Charges -$21.00M -$31.00M -$14.00M -$107.00M -$79.00M
Ending Cash Balance $1.98B $2.16B $2.02B $1.97B $1.97B
Net Change in Cash -$172.00M $137.00M $69.00M -$530.00M $239.00M
Beginning Cash Balance $2.16B $2.02B $1.97B $2.41B $1.73B
Effect of Exchange Rate Changes -$3.00M $0.00 -$18.00M $84.00M $1.00M
Free Cash Flow $448.00M $166.00M $76.00M $323.00M $444.00M
Net Investment Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on BAX.

Sign in to join the discussion.

Scroll to Top